Adhera Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.074 million compared to USD 0.428 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 2.4 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0039 USD | +2.63% | -13.33% | -87.00% |
1st Jan change | Capi. | |
---|---|---|
-87.00% | 45.34K | |
+16.71% | 121B | |
+13.06% | 107B | |
-5.53% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.29% | 15.31B | |
+1.38% | 14.08B | |
+24.22% | 11.74B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022